Biotech company AMAL Therapeutics (AMAL), a separate division of the Boehringer Ingelheim group of companies’ Discovery Research organisation, creates novel therapeutic vaccines. By boosting the patient’s immune system in a novel manner, we hope to address the difficulties associated with effective anti-cancer therapy.
AMAL Therapeutics
- Description
- Contact Form
